Business
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April
Hi, what are you looking for?
The Generic-drug maker took its bid directly to shareholders after being rebuffed since April
French telecom billionaire broadens his media holdings
A Credit Suisse study finds that most hostile bids fail, especially if antitrust concerns are involved.
Mylan's filing on executive compensation reveals much higher pay than at Teva.
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
U.S. regulators have rewritten their definition of broadband in a manner that portrays the largest U.S. cable company as a more dominant force in...
Carl Icahn is at it again, this time with Gannett, which he wants to split up into a newspaper unit, which includes USA Today...
It was a tough 2014 for Dreamworks, and now the nightmare continues, this time for employees as management plans to eliminate nearly a quarter...
The latest name to be linked with a possible takeover of the English Premier League’s Aston Villa is Microsoft co-founder Paul Allen, The Birmingham...
One would think that hedge managers would get rewarded or penalized for performance or the lack thereof, but apparently this isn’t so. By...